Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the A Randomized, Double-Blind, Phase Iii, Non-Inferiority Clinical Trial Comparing the Efficacy and Safety of Ta4415v (A Proposed Trastuzumab Biosimilar) and Herceptin (Trastuzumab Reference Product) in Her2-Positive Early-Stage Breast Cancer Patients
Maryam Nakhostin
Maryam Nakhostin

Assistant Professor of Infectious Disease

Department Infectious Disease and Tropical Medicine

School of Medicine

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences